TP53 and melanoma: As expected, given this molecule does not have an impact on DNA damage or other processes known to stabilize p53, we did not observe any changes in the endogenous expression of p53 isoforms in melanoma cell lines after treatment, except the reduction in Δ160p53α levels in Ma-Mel-54, -55, and -86a (Figure S6).